Illumina, early cancer-screening startup ramped up lobbying amid merger pressure
… reject DNA sequencer Illumina’s acquisition of the early cancer … fold in 2020, an acquisition that was challenged by both … the past few years as the merger has played out, both … Caucus [...]
